ADAG – adagene inc. - ads, each representing 1.25 ordinary shares (US:NASDAQ)
Stock Stats
News
Adagene (ADAG) had its price target raised by Guggenheim from $9.00 to $10.00. They now have a "buy" rating on the stock.
Adagene Announces Pricing of US$70.0 Million Public Offering of ADSs [Yahoo! Finance]
Adagene announces pricing of $70M public offering of ADS [Seeking Alpha]
Adagene Announces Pricing of US$70.0 Million Public Offering of ADSs
Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)
Form 424B5 Adagene Inc.
Form 6-K Adagene Inc. For: Apr 02
Form 424B5 Adagene Inc.
Form 6-K Adagene Inc. For: Apr 02
Form 6-K Adagene Inc. For: Apr 01
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.